Browse our anti-GUCA1B (GUCA1B) Antibodies

Mouse (Murine) Guanylate Cyclase Activator 1B (Retina) (GUCA1B) interaction partners

1. The GCAP1 and GCAP2 binding site(s) overlaps within the kinase homology and/or dimerization domains of retinal GC1.

2. This study identifies a new mechanism governing GCAP2 (show GUCA2B Antibodies) subcellular distribution in vivo, closely related to disease.

3. Overexpression of guanylate cyclase activating protein 2 in rod photoreceptors in vivo leads to morphological changes at the synaptic ribbon.

4. GCAP (show GUCA1A Antibodies)-activated native retinal membrane (Ret (show RET Antibodies))GC1 and RetGC2 (show GUCY2F Antibodies) are less sensitive to inhibition by calcium ions in the presence of GCAP1 (show GUCA1A Antibodies) than GCAP2 (show GUCA2B Antibodies).

5. GCAP2 (show GUCA2B Antibodies) is a prime candidate for mediating Ca2 (show CA2 Antibodies)+-dependent dynamic changes of synaptic ribbons in photoreceptor synapses

6. GCAP (show GUCA1A Antibodies) functions in intact photoreceptors [review]

7. GCAP2 (show GUCA2B Antibodies) regulation of guanylyl cyclase activity quickens the recovery of flash and step responses and adjusts the operating range of rods to higher intensities of ambient illumination

8. Prolonged illumination up-regulates retinal arrestin (show SAG Antibodies) and Guca1a (show GUCA1A Antibodies)/b: a novel mechanism for light adaptation.

Cow (Bovine) Guanylate Cyclase Activator 1B (Retina) (GUCA1B) interaction partners

1. Mapping Calcium-Sensitive Regions in the Neuronal Calcium Sensor GCAP2 by Site-Specific Fluorescence Labeling.

2. The C-terminal segment in GCAP2 confers target selectivity, facilitates membrane binding and provides sensitivity of the membrane localization of the protein to phosphorylation by rhodopsin kinase (show GRK1 Antibodies).

3. Based on the distance constraints imposed by the cross-links, the study derived a 3D-structural model of the GCAP2 homodimer.

4. Data suggest that dimerization domain of GUCY2D (show GUCY2D Antibodies) operates as a calcium-sensitive regulatory module; GUCY2D (show GUCY2D Antibodies) requires correct conformation of monomer-monomer interface for interaction with guanylate cyclase activating proteins (GCAP1 (show GUCA1A Antibodies); GCAP2).

5. interaction between N-terminally myristoylated GCAP-2 and a peptide derived from the catalytic domain of full-length ROS-GC 1

6. Ca2 (show CA2 Antibodies)+ exerted a stabilizing effect on both myristoylated and non-myristoylated forms of the protein, which was significantly stronger for myristoylated GCAP2.

7. GCAP2 is a prime candidate for mediating Ca2 (show CA2 Antibodies)+-dependent dynamic changes of synaptic ribbons in photoreceptor synapses

8. Findings show that the sequence motif of the core GCAP2-modulatory site is Tyr965-Asn981 of rod outer segment membrane guanylate cyclase (show GUCY2D Antibodies) type 1 (ROS-GC1); this site is absolutely specific for GCAP2 and does not overlap with the GCAP1 (show GUCA1A Antibodies)-modulated site.

9. Our data indicate that the Ca(2 (show CA2 Antibodies)+)-sensitivity of GCAP2 is significantly controlled by its third Ca(2 (show CA2 Antibodies)+)-binding site, EF-hand 3.

Human Guanylate Cyclase Activator 1B (Retina) (GUCA1B) interaction partners

1. Dimerization domain of RETGC1 (show GUCY2D Antibodies) is an essential part of GCAP1 (show GUCA1A Antibodies) and GCAP2 binding interface.

2. The GCAP1 and GCAP2 binding site(s) overlaps within the kinase homology and/or dimerization domains of retinal GC1.

3. The absence of clearly pathogenic mutations in the selected patient group suggests that the GUCA1B gene is a minor cause for retinal degenerations in Europeans or North-Americans.

4. Mutation in the GCAP 2 gene can cause one form of autosomal dominant retinal dystrophy (show MERTK Antibodies), with variable phenotypic expression and incomplete penetrance.